Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 0
---
<div align='center'>As confidentially submitted on April [ ], 2025 to the Securities and Exchange Commission.

This draft registration statement has not been filed publicly with the Securities and Exchange

Commission and all information contained herein remains strictly confidential.</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

bioAffinity Technologies, Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware                 |     |                8731 |     | 46-5211056     |
| (State                   
 or other jurisdiction of 
 incorporation            
 or organization)         |     |            -Primary 
 Standard Industrial 
      Classification 
         Code Number |     | -I.R.S.        
 Employer       
 Identification 
 Number         |

<div align='center'>3300 Nacogdoches Road

Suite 216

San Antonio, Texas 78217

(210) 698-5334

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Maria Zannes

Chief Executive Officer

3300 Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(210) 698-5334

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:</div>

| Leslie                 
 Marlow, Esq.           
 Melissa                
 Palat Murawsky, Esq.   
 Blank                  
 Rome LLP               
 1271                   
 Avenue of the Americas 
 New                    
 York, New York 10020   
 Tel:                   
 (212) 885-5000         | Ross                               
 Carmel, Esq.                       
 Jeffrey                            
 Wofford, Esq.                      
 Sichenzia                          
 Ross Ference Carmel LLP            
 1185                               
 Avenue of the Americas, 31st Floor 
 New                                
 York, NY 10036                     
 (212)                              
 930-9700                           |

Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

If this Form is filed to